The selectivity of DG-5128 as an α2-adrenoceptor antagonist
- 27 November 1984
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 106 (3), 625-628
- https://doi.org/10.1016/0014-2999(84)90068-2
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 7 references indexed in Scilit:
- Evidence for pharmacological similarity between α2,-adrenoceptors in the vas deferens and central nervous system of the ratBritish Journal of Pharmacology, 1983
- Insulin releasing action of 2-[2-(4,5-dihydro-1H-imadazol-2-yl)-1-phenylethyl] pyridine dihydrochloride sesquihydrate (DG-5128), a new, orally effective hypoglycaemic agentActa Endocrinologica, 1982
- Comparative study on the effects of a hypoglycemic 2-substituted-2-imidazoline derivative (DG-5128) and tolbutamide on insulin secretion from and insulin synthesis in the isolated rat pancreatic isletsBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium propertiesLife Sciences, 1981
- Alpha adrenoceptors in rat brain: Direct identification with prazosinNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1979
- Pharmacological and biochemical properties of isomeric yohimbine alkaloidsEuropean Journal of Pharmacology, 1978
- Alpha-noradrenergic receptor binding in mammalian brain: Differential labeling of agonist and antagonist statesLife Sciences, 1976